Dr. Michael Serzan emphasizes the importance of clinical trial participation for patients with kidney cancer.

Patients with blood cancers like polycythemia vera, a kind of myeloproliferative neoplasm, may benefit in learning more about ...

Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing ...

It’s a bad day when a doctor says you have cancer. It’s a worse day when he says it’s stage prostate cancer with a metastatic ...

Surviving cancer wasn’t the end of my story; it was the start of redefining life, finding purpose and offering hope to those ...

Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal ...

Dr. Prantesh Jain and Dr. Joshua Sabari delved into the numerous advances in NSCLC following 2025 ASCO, highlighting the ...

CURE connects oncology patients, survivors, and caregivers with expert guidance, cancer updates, treatment education, and ...

I can still clearly remember people’s reactions after I finished chemo for the first time in 2014, a few months after my ...

Speaking up during cancer treatment helped one patient manage side effects, address insurance issues and stay productive ...

FDA approves updated labeling for Talzenna plus Xtandi in men with HRR gene-mutated metastatic prostate cancer, showing a ...

Surviving later-stage lung or colon cancer comes about as a result of a combination of healthy eating, remaining as active as ...